Nigerian Center for Disease Control (NCDC) on Tuesday cautioned that Dexamethsaone has not been approved for the treatment of the COVID-19 patients in Nigeria.
Scientists in the United Kingdom had hailed the drug, a widely hailed used low-dose steroid, as a major breakthrough after it found to have greatly reduced the risk of dying from COVID-19.
The NCDC in series of tweets on its official twitter handle, said: The Nigeria Centre for Disease Control (NCDC) is aware of recent outcomes from a UK-Government funded clinical trial for COVID-19.
The results support the use of Dexamethsaone as a possible treatment to reduce the risk of death among COVID-19 patients, who require oxygen or mechanical ventilation.
Please note that the Government of Nigeria has not apporved any treatment for COVID-19. Besides, the use of Dexamethsaone for COVID-19 treatment has not been approved by WHO.
We are aware of ongoing clinical trials conducted by scientists in the UK and will work with our sister agencies to evaluate this emerging data on the use of Dexamethasone. We will inform the general public on outcomes following scientific review and validation.
Source: Politics Nigeria